Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of
reasons. Viruses are thought to be important environmental elements that contribute to the …

Background Myasthenia gravis (MG) is a rare but life-threatening adverse event of immune
checkpoint inhibitors (ICI). Given the limited evidence, data from a large cohort of patients is …

Background Generalised myasthenia gravis is a chronic, unpredictable, and debilitating rare
disease, often accompanied by high treatment burden and with an unmet need for more …

Background Generalized myasthenia gravis (gMG) is a rare, chronic, and debilitating
autoimmune disease. Activation of the complement system by autoantibodies against the …

Background The development of immune checkpoint inhibitors (ICIs) represents a paradigm
shift in the treatment of cancers. Despite showing remarkable efficacy, these agents can be …

Summary Myasthenia gravis and Lambert-Eaton myasthenic syndrome are antibody-
mediated autoimmune diseases of the neuromuscular junction that usually present with …

No consensus has been reached on the ideal therapeutic algorithm for myasthenia gravis
(MG). Most patients with MG require induction therapy with high doses of corticosteroids and …

Objective To determine demographic characteristics, clinical features, treatment regimens,
and outcome of myasthenic crisis (MC) requiring mechanical ventilation (MV). Methods …

Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the
acetylcholine receptors or associated structures of the postsynaptic membrane of the …

Myasthenia gravis (MG) is a chronic autoimmune disease with fluctuating muscle weakness
and fatigability. Standard immunomodulatory treatment may fail to achieve sufficient …